AEMD

Aethlon Medical, Inc. · NASDAQ

Sector Health Technology
Industry Medical Specialties
Website aethlonmedical.com
Employees(FY) 15
ISIN US00808Y4061

Performance

+25.98%

1W

-30.27%

1M

-58.25%

3M

-60.85%

6M

-68.36%

YTD

-79.5%

1Y

Profile

Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. The company was founded in 1999 and is based in San Diego, California.

Advanced Technical Analysis

Technical Analysis of AEMD 2024-05-31

Overview:

In analyzing the technical indicators for AEMD over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and predictions for potential inv...

See more ...

Recent News & Updates

2024-06-06 20:00
The Hunt for Virus Treatments Continues Post Covid-19(Newsfilecorp)
2024-06-05 20:12
Why Is Aethlon Medical (AEMD) Stock Up 82% Today?(Investorplace)
2024-06-05 19:38
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday(Investorplace)
2024-06-02 21:05
Blood Purification Medical Devices Revolutionizing the Future of Health from Cancer to COVID(Newsfilecorp)
2024-06-02 20:01
Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment Studies(Prnewswire)
2024-05-15 01:34
Top Midday Decliners(Yahoo Finance)
2024-05-14 21:15
Aethlon Medical Announces Pricing of $4.7 Million Public Offering(Prnewswire)
2024-05-14 19:29
Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday(Investorplace)
2024-05-09 20:01
Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier in Removing Extracellular Vesicles From Cancer Patient Plasma(Prnewswire)
2024-02-20 19:01
Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices(Prnewswire)
2024-02-14 21:03
Aethlon Medical, Inc. (NASDAQ:AEMD) Q3 2024 Earnings Call Transcript(Yahoo Finance)
2024-02-14 03:15
Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update(Prnewswire)
2024-02-06 19:00
Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024(Prnewswire)
2023-11-15 20:35
Aethlon Medical, Inc. (NASDAQ:AEMD) Q2 2024 Earnings Call Transcript(Insidermonkey)
2023-11-14 03:15
Aethlon Medical Announces Fiscal Second Quarter Financial Results and Provides Corporate Update(Prnewswire)
2023-11-12 19:01
Aethlon Medical Announces Appointment of James B. Frakes, M.B.A. as Interim Chief Executive Officer and Guy Cipriani, M.B.A. as Chief Operating Officer(Prnewswire)
2023-11-05 19:01
Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2023(Prnewswire)
2023-10-11 22:19
AEMD: Authorization to Conduct Study in India Moves Oncology Initiatives Ahead(Yahoo Finance)
2023-10-09 20:01
Aethlon Receives Clearance From Drug Controller General of India For Potential Phase 1 Trial of its Hemopurifier in Oncology(Prnewswire)
2023-10-03 20:01
Aethlon Announces Reverse Stock Split(Prnewswire)
2023-08-29 20:01
Aethlon Medical to Present at the H.C. Wainwright 25th Annual Global Investment Conference(Yahoo Finance)
2023-08-13 20:03
AEMD: Focusing on Oncology, Infectious Disease & Organ Transplants Initially(Yahoo Finance)
2023-08-10 04:15
Aethlon Medical Announces Fiscal First Quarter Financial Results and Provides Corporate Update(Yahoo Finance)
2023-08-02 20:01
Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 10, 2023(Yahoo Finance)
2023-07-23 20:01
Aethlon Medical Signs Collaboration Agreement with 34 Lives to Evaluate the Ability of the Hemopurifier® to Expand the Utility of Unused, Donated Kidneys for Transplant(Yahoo Finance)
2023-07-06 02:17
Aethlon Medical Appoints Medical Device and Biomedical Executive, Nicolas Gikakis, to its Board of Directors(Yahoo Finance)
2023-07-06 00:10
AEMD: Expanding Research Efforts & Strengthening Team, While Minimizing R&D Spending(Yahoo Finance)
2023-06-30 00:42
Aethlon Medical, Inc. (NASDAQ:AEMD) Q4 2023 Earnings Call Transcript(Yahoo Finance)
2023-06-28 04:15
Aethlon Medical Announces Fiscal Year End Financial Results and Provides Corporate Update(Yahoo Finance)
2023-06-21 20:01
Aethlon Medical to Release Fourth Quarter and Year End Financial Results and Host Conference Call on June 28, 2023(Yahoo Finance)

Page 1 of 4

previousnext